Gefitinib ('Iressa', ZD1839) in advanced non-small-cell lung cancer patients progressed to chemotherapy

被引:0
|
作者
Cortes-Funes, H
Figueiras, MC
Martín-Algarra, S
Salinas, P
Massutí, B
Gascón, P
Rosell, R
机构
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Pontevedra, Pontevedra, Spain
[3] Univ Navarra Clin, Navarra, Spain
[4] MD Anderson Int Canc Ctr, Madrid, Spain
[5] Gen Hosp, Alicante, Spain
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Hosp Germans Trias & Pujol, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S27 / S27
页数:1
相关论文
共 50 条
  • [1] Gefitinib ('Iressa', ZD1839) as treatment for non-small-cell lung cancer
    Razis, E
    Papadopoulos, S
    Skarlos, D
    Exarchakos, M
    Christodoulou, C
    Karina, M
    Xylouri, M
    Labropoulos, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [2] Gefitinib ('Iressa', ZD1839) in relapsed non-small-cell lung cancer
    Reck, M
    Gatzemeier, U
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S33
  • [3] Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer
    Hotta, K
    Kiura, K
    Ueoka, H
    Tabata, M
    Fujiwara, K
    Kozuki, T
    Okada, T
    Hisamoto, A
    Tanimoto, M
    [J]. LUNG CANCER, 2004, 46 (02) : 255 - 261
  • [4] Gefitinib ('Iressa', ZD1839) in heavily pretreated patients with metastatic non-small-cell lung cancer
    Martín-Algarra, S
    Gurpide, A
    Lopez-Picazo, JM
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S30 - S30
  • [5] Gefitinib ('Iressa', ZD1839) given in the 'Iressa' Expanded Access Programme in patients with non-small-cell lung cancer
    Chioni, A
    Barbieri, F
    Baldini, E
    Orlandini, C
    Ricci, S
    Conte, PF
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S27
  • [6] Use of gefitinib ('Iressa', ZD1839) in advanced non-small-cell lung cancer for routine clinical practice
    Bendel, J
    Häusler, J
    Korfee, S
    Antoch, G
    Gauler, T
    Eberhardt, W
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S25 - S25
  • [7] Efficacy of gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer metastatic to the brain
    Diaz-Cantón, E
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S28
  • [8] Efficacy of gefitinib ('Iressa', ZD1839) in a patient with advanced non-small-cell lung cancer with metastatic spread to the brain
    Petruzelka, L
    Zemanova, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [9] Gefitinib ('Iressa', ZD1839) for patients with advanced non-small-cell lung cancer treated in the 'Iressa' Expanded Access Programme at a single institution in Brazil
    Katz, A
    Smaletz, O
    Simon, SD
    Rene, GC
    Hoff, PM
    Tabacof, J
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S29 - S29
  • [10] Gefitinib (Iressa, ZD 1839) A Potential Chemotherapy Sensitizer in Previously Chemotherapy Nonresponded Advanced Non-Small-Cell Lung Cancer Patients
    Dudnik, Julia
    Lazarev, Irina
    Ariad, Shmuel
    Mermershtain, Wilmosh
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2006, 27 (02) : 40 - 41